Mark Rachesky

Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ.

Navistar International Corp. is a holding company, which engages in the manufacture of military truck, proprietary diesel engines, school and commercial buses, and service parts for trucks and diesel engines. It operates through the following segments: Truck, Parts, Global Operations, and Financial Services. The Truck segment manufactures and distributes class four through eight trucks, buses, military and government vehicles under the International, and IC Bus (IC) brands, and produces engines under its proprietary brand name and parts required to support the military truck lines. The Parts segment offers proprietary products needed to support the International commercial truck, IC Bus, proprietary engine lines, and export parts business, as well as its other product lines. The Global Operations segment comprises of Brazil engine operations which produce diesel engines under contract manufacturing arrangements. The Financial Services segment includes retail, wholesale, and lease financing of products sold by the truck and parts segments, and dealers within the United States, and Mexico. The company was founded in 1902 and is headquartered in Lisle, IL.

The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.

Samsonite LLC provides travel solutions. It designs and manufactures travel, luggage bags and accessories. The firm offers service and repair for its products. The company was founded in 1910 and is headquartered in Mansfield, MA.

Loral Space & Communications, Inc. engages in the provision of satellite-based communication services to broadcast, enterprise, and consulting customers. It offers video distribution and direct-to-home video, as well as end-to-end communications services using both satellite and hybrid satellite-ground networks. The company was founded in 1948 and is headquartered in New York, NY.

Maxar Space LLC designs and manufactures weather and communications satellites, subsystems and payloads. The firm's services includes television and radio distribution, digital audio radio, broadband Internet, and mobile communications. The company was founded in 1957 and is headquartered in Palo Alto, CA.

NovaDel Pharma, Inc. engages in developing oral spray formulations for different types of drugs. It develops oral spray and pharmaceutical products for angina pectoris, insomia, migraine headaches, and disorders of the central nervous system. The company was founded in 1982 and is headquartered in Bridgewater, NJ.